Foldax Inc.
PrivateLast Round
Series D
Jun 22, 2020
Total Funding Raised
$20M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Foldax Inc. is a medical device company focused on reinventing heart valves to create treatments that can last a lifetime. The company develops synthetic, biopolymer heart valves (the TRIA platform) designed to address the historical trade-offs between traditional tissue and mechanical valves. Its proprietary LifePolymer material is intended to be more durable and reduce the risk of calcification, potentially eliminating the need for lifelong anticoagulant medication for patients. Foldax utilizes robotic manufacturing to ensure precision, consistency, and quality, which also improves the economics of production. The company is conducting clinical trials for its aortic and mitral valves and has received approval for commercial use of its TRIA mitral valve in India.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Advanced Materials, Clinical Trials, Smart Manufacturing
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Foldax Inc. Comparables
Compare Foldax Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Novostia | 85% | |
| PECA Labs, Inc. | 84% | |
| Thubrikar Aortic Valve, Inc. | 79% |
Foldax Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Jun 22, 2020 | ||||
| VC Round | Dec 19, 2018 | ||||
| Series A | Aug 31, 2015 |
Foldax Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Summation Health Ventures | VC Round |
| California Institute of Technology Investment Office | Series D, VC Round |
| Kairos Ventures | Series D, VC Round, Series A |
| BioStar Capital | Series D, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 193% MoM, reaching 1.4K.
- Jun 19, 2026
Monthly visitors increased 77% MoM.
Foldax Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Foldax Inc.'s valuation, stock price, and market status.
Is Foldax Inc. a public or private company?
Foldax Inc. is a private company.
What is the current stock price of Foldax Inc.?
Foldax Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Foldax Inc. worth (valuation)?
Valuation information for Foldax Inc. is not publicly available.
Can I buy Foldax Inc. stock?
Foldax Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Foldax Inc.'s last funding round?
Foldax Inc.'s most recent funding round was Series D on June 22, 2020.
Who are the main investors in Foldax Inc.?
Key investors in Foldax Inc. include Kairos Ventures.
Will Foldax Inc. IPO soon?
No public IPO plans have been announced for Foldax Inc..
How can I track Foldax Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Foldax Inc.'s secondary market activity and sign up for updates.